MND: An Israeli work published in 2006 in the Journal of Leukocyte biology paved way for subsequent studies of extracts of the hydrangea bush as a treatment for auto immune diseases such as MS:
Quoting: “… Halofuginone inhibits activated peripheral blood T cell functions and proinflammatory cytokine production…It also inhibited DTH response in vivo, making it an attractive immunomodulator and anti-inflammatory agent….” Click Here for link to article’s entry in PubMed
MND: A later study published in the Journal “Nature” further concludes: “…halofuginone is a specific inhibitor of TH17 cell differentiation . …..[TH17] known to have a role in the induction of autoimmune diseases…..].
MND:Quoting an entry in BigNews.biz :
“…halofuginone promises to be a gentler and more effective drug. It is found to suppress the production of a particular immune system cell, the Th17,..”